BioHarvest Sciences Inc. (CNVCF, BHSC.CN) Ilan Sobel, CEO

The Wall Street Resource

A leader in Botanical Synthesis, leveraging its

patented technology process to grow plant-based molecules, without the need to

grow the underlying plant. BioHarvest is leveraging its botanical synthesis

technology to develop the next generation of science-based and clinically

proven therapeutic solutions within two major business verticals; as a contract

development and production organization (CDMO) on behalf of customers seeking

complex molecules, and as a creator of proprietary nutraceutical health and wellness

products, which includes dietary supplements.